project id: TCGA-HNSC; case submitter id: TCGA-TN-A7HJ; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 8.2; age at index: 51; days to birth: -18809; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18809; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical stage: Stage III; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 403.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 45; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-TN-A7HJ-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 35.0; percent stromal cells: 0.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;